Funding Rounds
Flarin

Flarin Series A (2023, $6M)

Flarin

Patent-protected anti-inflammatory painkiller.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $6.30M

Investors